Jon Schott News Today

A stark warning that cases of dementia will soar over the next two decades comes amid hope and optimism the condition will become treatable.

EXCLUSIVE: Full results from donanemab trials are to be published for the first time which will show if the new wonder drug could slow down dementia.

EXCLUSIVE: A new drug has been shown to slow the rate at which memory and thinking skills decline.

44 long-form articles that put the spotlight on groundbreaking new research and compelling human interest stories from around the world

While all the organization’s previous ministries are still in place, the bigger building allows them the chance to offer even more, including access to showers.

Veteran-run Bo & Ivy is making gin, vodka, and corn whiskey.

Study shows cognition in early-stage patients on lecanemab declines by 27% less than those on placebo

Study shows the drug, lecanemab, drug slows down cognition decline by 27% compared to placebo-treated patients in a phase 3 clinical trial.

Idaho’s largest health care system is getting into the insurance business. St. Luke’s Health System has launched St. Luke’s Health Plan, a nonprofit health insurance plan offering coverage to individuals and families across 20 Idaho counties beginning in January. The new plan will cover health care from St. Luke’s and 4,000 independent physicians in Idaho. That network ...

The building was constructed and enclosed on Court Street late last fall, and work on the interior has continued throughout the winter.